1. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. (June 2021) Authors: Avouac, Jérôme; Drumez, Elodie; Hachulla, Eric; Seror, Raphaèle; Georgin-Lavialle, Sophie; El Mahou, Soumaya; Pertuiset, Edouard; Pham, Thao; Marotte, Hubert; Servettaz, Amélie; Domont, Fanny; Chazerain, Pascal; Devaux, Mathilde; Claudepierre, Pascal; Langlois, Vincent; Mekinian, Arsène; Maria, A... Journal: Lancet Issue: Volume 3:Number 6(2021) Page Start: e419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cross-reactive anti-CENP-A autoantibodies induce analytic interference in anti-TIF1γ detection using line-dot immunoassay. (22nd May 2021) Authors: Gensous, Noémie; Zanardo, Laura; Martinroche, Guillaume; Victor, Judith; Fabien, Nicole; Duffau, Pierre; Contin-Bordes, Cécile Journal: Rheumatology Issue: Volume 60:Number 10(2021) Page Start: 4942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗